emjreviews.com2d
FDA greenlights UCB’s IL-17 inhibitor for HS
The novel IL-17A and IL-17F inhibitor has been approved for moderate to severe hidradenitis suppurativa, a chronic and ...
Medscape4d
FDA Approves Bimekizumab for Adults With Hidradenitis Suppurativa
The US Food and Drug Administration has approved bimekizumab, a humanized interleukin (IL)-17A and IL-17F antagonist, for the treatment of adults with moderate to severe hidradenitis suppurativa (HS).
McKnight's Long-Term Care News26d
FDA approves new antibiotic for uncomplicated UTIs
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs). Orlynvah (sulopenem etzadroxil and probenecid) is a broad-spectrum ...
NBC Los Angeles on MSN5d
FDA weighs in on diet drug shortage, creating more confusion about compounding
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
Medscape15d
FDA Approved Obe-cel, a Novel CD19 CAR T Product for ALL
Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.